ArticleAnnals of neurology2012

Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica.

Lawrence Steinman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.